Increased catalase expression improves muscle function in mdx mice

Experimental Physiology

Volumn 96, Issue 2, 2011, Pages 194-202

  Selsby, Joshua T ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; DYSTROPHIN; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAPHRAGM; DUCHENNE MUSCULAR DYSTROPHY; EXTENSOR DIGITORUM LONGUS MUSCLE; GENE OVEREXPRESSION; LIMB; MOUSE; MOUSE STRAIN; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE TONE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; SKELETAL MUSCLE; SOLEUS MUSCLE; TRANSGENE;

EID: 78751498734     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2010.054379     Document Type: Article

References (47)

1. Anderson JE, Ovalle WK & Bressler BH (1987). Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse. Anat Rec 219, 243-257.
2. Balice-Gordon RJ & Lichtman JW (1993). In vivo observations of pre- and postsynaptic changes during the transition from multiple to single innervation at developing neuromuscular junctions. J Neurosci 13, 834-855.
3. Barton ER (2006a). Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle. Am J Physiol Cell Physiol 290, C411-C419.
4. Barton ER (2006b). Viral expression of insulin-like growth factor-I isoforms promotes different responses in skeletal muscle. J Appl Physiol 100, 1778-1784.
5. Barton ER (2010). Restoration of γ-sarcoglycan localization and mechanical signal transduction are independent in murine skeletal muscle. J Biol Chem 285, 17263-17270.
6. Barton ER, Morris L, Kawana M, Bish LT & Toursel T (2005). Systemic administration of l-arginine benefits mdx skeletal muscle function. Muscle Nerve 32, 751-760.
7. Barton ER, Wang BJ, Brisson BK & Sweeney HL (2010). Diaphragm displays early and progressive functional deficits in dysferlin-deficient mice. Muscle Nerve 42, 22-29.
8. Blake DJ, Weir A, Newey SE & Davies KE (2002). Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82, 291-329.
9. Bornman L, Rossouw H, Gericke GS & Polla BS (1998). Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy. Biochem Pharmacol 56, 751-757.
10. Brooks SV & Faulkner JA (1988). Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 404, 71-82.
11. Buetler TM, Renard M, Offord EA, Schneider H & Ruegg UT (2002). Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am J Clin Nutr 75, 749-753.
12. Bulfield G, Siller WG, Wight PA & Moore KJ (1984). X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81, 1189-1192.
13. Dangain J & Vrbova G (1984). Muscle development in mdx mutant mice. Muscle Nerve 7, 700-704.
14. Disatnik MH, Dhawan J, Yu Y, Beal MF, Whirl MM, Franco AA & Rando TA (1998). Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state. J Neurol Sci 161, 77-84.
15. Dodd SL, Gagnon BJ, Senf SM, Hain BA & Judge AR (2010). Ros-mediated activation of NF-κB and Foxo during muscle disuse. Muscle Nerve 41, 110-113.
16. Fenichel GM, Brooke MH, Griggs RC, Mendell JR, Miller JP, Moxley RT 3rd et al (1988). Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E. Muscle Nerve 11, 1164-1168.
17. Gamstorp I, Gustavson KH, Hellstrom O & Nordgren B (1986). A trial of selenium and vitamin E in boys with muscular dystrophy. J Child Neurol 1, 211-214.
18. Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J & Wilson JM (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 99, 11854-11859.
19. Hauser E, Hoger H, Bittner R, Widhalm K, Herkner K & Lubec G (1995). Oxyradical damage and mitochondrial enzyme activities in the mdx mouse. Neuropediatrics 26, 260-262.
20. Haycock JW, MacNeil S, Jones P, Harris JB & Mantle D (1996). Oxidative damage to muscle protein in Duchenne muscular dystrophy. Neuroreport 8, 357-361.
21. Hunter JR, Galloway JR, Brooke MM, Kutner MH, Rudman D, Vogel RL, Wardlaw CF & Gerron GG (1983). Effects of allopurinol in Duchenne's muscular dystrophy. Arch Neurol 40, 294-299.
22. Jackson MJ, Jones DA & Edwards RH (1984). Techniques for studying free radical damage in muscular dystrophy. Med Biol 62, 135-138.
23. Kaczor JJ, Hall JE, Payne E & Tarnopolsky MA (2007). Low intensity training decreases markers of oxidative stress in skeletal muscle of mdx mice. Free Radic Biol Med 43, 145-154.
24. Li Z, Marchand P, Humbert J, Babinet C & Paulin D (1993). Desmin sequence elements regulating skeletal muscle-specific expression in transgenic mice. Development 117, 947-959.
25. Mechler F, Imre S & Dioszeghy P (1984). Lipid peroxidation and superoxide dismutase activity in muscle and erythrocytes in Duchenne muscular dystrophy. J Neurol Sci 63, 279-283.
26. Mendell JR & Wiechers DO (1979). Lack of benefit of allopurinol in Duchenne dystrophy. Muscle Nerve 2, 53-56.
27. Messina S, Altavilla D, Aguennouz M, Seminara P, Minutoli L, Monici MC, Bitto A, Mazzeo A, Marini H, Squadrito F & Vita G (2006). Lipid peroxidation inhibition blunts nuclear factor-κB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am J Pathol 168, 918-926.
28. Morine K, Sleeper MM, Barton ER & Sweeney L (2010). Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction induced damage. Hum Gene Ther, doi:.
29. Murphy KT, Ryall JG, Snell SM, Nair L, Koopman R, Krasney PA, Ibebunjo C, Holden KS, Loria PM, Salatto CT & Lynch GS (2010). Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice. Am J Pathol 176, 2425-2434.
30. Murphy ME & Kehrer JP (1986). Free radicals: a potential pathogenic mechanism in inherited muscular dystrophy. Life Sci 39, 2271-2278.
31. Murphy ME & Kehrer JP (1989). Oxidative stress and muscular dystrophy. Chem Biol Interact 69, 101-173.
32. Nowak KJ & Davies KE (2004). Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep 5, 872-876.
33. Pastoret C & Sebille A (1993). Further aspects of muscular dystrophy in mdx mice. Neuromuscul Disord 3, 471-475.
34. Pastoret C & Sebille A (1995). mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 129, 97-105.
35. Rando TA, Crowley RS, Carlson EJ, Epstein CJ & Mohapatra PK (1998a). Overexpression of copper/zinc superoxide dismutase: a novel cause of murine muscular dystrophy. Ann Neurol 44, 381-386.
36. Rando TA, Disatnik MH, Yu Y & Franco A (1998b). Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul Disord 8, 14-21.
37. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, Wallace DC & Rabinovitch PS (2005). Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308, 1909-1911.
38. Selsby JT & Dodd SL (2005). Heat treatment reduces oxidative stress and protects muscle mass during immobilization. Am J Physiol Regul Integr Comp Physiol 289, R134-R139.
39. Selsby JT, Pendrak K, Zadel M, Tian Z, Pham J, Carver T, Acosta P, Barton ER & Sweeney HL (2010). Leupeptin based inhibitors do not improve the mdx phenotype. Am J Physiol Regul Integr Comp Physiol 299, R1192-1201.
40. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT & Kelly AM (1991). The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536-539.
41. Stern LZ, Ringel SP, Ziter FA, Menander-Huber KB, Ionasescu V, Pellegrino RJ & Snyder RD (1982). Drug trial of superoxide dismutase in Duchenne's muscular dystrophy. Arch Neurol 39, 342-346.
42. Straub V & Campbell KP (1997). Muscular dystrophies and the dystrophin-glycoprotein complex. Curr Opin Neurol 10, 168-175.
43. Tamari H, Ohtani Y, Higashi A, Miyoshino S & Matsuda I (1982). Xanthine oxidase inhibitor in Duchenne muscular dystrophy. Brain Dev 4, 137-143.
44. Thomson WH (1985). Clinical trials of allopurinol in Duchenne muscular dystrophy. Med Hypotheses 17, 175-189.
45. o site of mitochondrial complex III is the source of increased superoxide after transient exposure to hydrogen peroxide. J Mol Cell Cardiol 49, 875-885.
46. Whitehead NP, Pham C, Gervasio OL & Allen DG (2008). N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 586, 2003-2014.
47. Zhu HL, Stewart AS, Taylor MD, Vijayasarathy C, Gardner TJ & Sweeney HL (2000). Blocking free radical production via adenoviral gene transfer decreases cardiac ischemia-reperfusion injury. Mol Ther 2, 470-475.